Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation

Ann Oncol. 1996 Jul;7(5):441-4. doi: 10.1093/oxfordjournals.annonc.a010631.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inducing Agents / physiology
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Neoplasms / drug therapy*
  • Neovascularization, Pathologic / drug therapy*
  • Neovascularization, Physiologic / physiology
  • Prognosis

Substances

  • Angiogenesis Inducing Agents
  • Antineoplastic Agents